Access the full text.
Sign up today, get DeepDyve free for 14 days.
Bell (2010)
Long-term safety of recombinant human growth hormone in childrenJ Clin Endocrinol Metab, 95
Maghnie (2022)
Safety and efficacy of pediatric growth hormone therapy: results from the full KIGS cohortJ Clin Endocrinol Metab, 107
Swerdlow (2017)
Cancer risks in patients treated with growth hormone in childhood: the SAGhE European cohort studyJ Clin Endocrinol Metab, 102
Wilton (2010)
Growth hormone treatment in children is not associated with an increase in the incidence of cancer: experience from KIGS (Pfizer International Growth Database)J Pediatr, 157
Child (2019)
Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational programJ Clin Endocrinol Metab, 104
The Journal of Clinical Endocrinology & Metabolism, 2023, 108, e354–e355 https://doi.org/10.1210/clinem/dgad054 Advance access publication 31 January 2023 Letter to the Editor Letter to the Editor From Virú-Loza and Chávez-Nomberto: “Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort” 1 2 Manuel André Virú-Loza and Ruth Elizabeth Chávez-Nomberto Department of Pediatrics, Hospital Nacional Dos de Mayo, Lima, Peru Postgraduate School, Universidad Nacional Federico Villarreal, Lima, Peru Correspondence: Manuel André Virú-Loza, MD, MSc, Department of Pediatrics, Hospital Nacional Dos de Mayo, 2790 Brasil Ave, Pueblo Libre, Lima, Peru. Email: [email protected]. Key Words: human growth hormone, dwarfism, bone neoplasms, urinary bladder neoplasms, lymphoma, child Abbreviations: AE, adverse effect; GeNeSIS, Genetics and Neuroendocrinology of Short Stature International Study; KIGS, Kabi/Pfizer International Growth Database; rhGH, recombinant human growth hormone; SAE, serious adverse effect; SIR, standardized incidence ratio. We read with great interest the study by Maghnie et al (1) Hormone Treatments in Europe (SAGhE) study showed a sig- about the safety and efficacy of recombinant human growth nificantly increased risk of bone (SIR 5.2; 95% CI, 2.7-10.1) hormone (rhGH) in children from the full Kabi/Pfizer and bladder (SIR 14.0; 95% CI, 4.5-43.4) cancer in patients International Growth Database (KIGS)
The Journal of Clinical Endocrinology & Metabolism – Oxford University Press
Published: Jan 31, 2023
Keywords: human growth hormone; dwarfism; bone neoplasms; urinary bladder neoplasms; lymphoma; child
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.